AbCellera Biologics(ABCL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABCL AbCellera Biologics

交易中 07-10 12:38:26 EDT

4.29

+0.07

+1.62%

最高4.33	最低4.14	成交量221.76万
今开4.29	昨收4.22	日振幅4.50%
总市值12.80亿	流通市值8.68亿	总股本2.98亿
成交额938.40万	换手率1.10%	流通股本2.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABCL","market":"US","secType":"STK","nameCN":"AbCellera Biologics","latestPrice":4.2884,"timestamp":1752165495049,"preClose":4.22,"halted":0,"volume":2217630,"delay":0,"floatShares":202401614,"shares":298484664,"eps":-0.567947,"marketStatus":"交易中","change":0.0684,"latestTime":"07-10 12:38:26 EDT","open":4.29,"high":4.33,"low":4.14,"amount":9384024.423465,"amplitude":0.045024,"askPrice":4.29,"askSize":1022,"bidPrice":4.28,"bidSize":1812,"shortable":3,"etf":0,"ttmEps":-0.567947,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752177600000},"marketStatusCode":2,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":4.22,"preHourTrading":{"tag":"盘前","latestPrice":4.3,"preClose":4.22,"latestTime":"09:29 EDT","volume":63600,"amount":272628.2052,"timestamp":1752154170060},"postHourTrading":{"tag":"盘后","latestPrice":4.2599,"preClose":4.22,"latestTime":"19:58 EDT","volume":56484,"amount":238430.8182,"timestamp":1752105538126},"volumeRatio":0.758176,"impliedVol":1.0082,"impliedVolPercentile":0.596},"requestUrl":"/m/hq/s/ABCL","defaultTab":"news","newsList":[{"id":"2550654991","title":"Abcellera Biologics Inc.盘中异动 快速上涨5.01%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550654991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550654991?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:17","pubTimestamp":1752077853,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日00时17分，Abcellera Biologics Inc.股票出现波动，股价急速拉升5.01%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710001733979fd9d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710001733979fd9d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4121","ABCL"],"gpt_icon":0},{"id":"2549559863","title":"Abcellera Biologics Inc.盘中异动 临近午盘大幅上涨5.00%报3.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549559863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549559863?lang=zh_cn&edition=full","pubTime":"2025-07-07 23:56","pubTimestamp":1751903799,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日23时56分，Abcellera Biologics Inc.股票出现异动，股价快速拉升5.00%。截至发稿，该股报3.99美元/股，成交量282.715万股，换手率0.95%，振幅7.34%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707235639979d350a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707235639979d350a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2548819232","title":"Abcellera Biologics Inc.盘中异动 股价大涨5.16%报3.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548819232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548819232?lang=zh_cn&edition=full","pubTime":"2025-07-03 00:12","pubTimestamp":1751472755,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日00时12分，Abcellera Biologics Inc.股票出现波动，股价急速拉升5.16%。截至发稿，该股报3.67美元/股，成交量337.917万股，换手率1.13%，振幅8.31%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703001235a72af590&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703001235a72af590&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4121","ABCL"],"gpt_icon":0},{"id":"2548017265","title":"Abcellera Biologics Inc.盘中异动 急速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548017265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548017265?lang=zh_cn&edition=full","pubTime":"2025-07-01 03:59","pubTimestamp":1751313546,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日03时59分，Abcellera Biologics Inc.股票出现异动，股价快速下挫5.26%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070103590795319e39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070103590795319e39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4535","BK4121"],"gpt_icon":0},{"id":"2546725523","title":"Abcellera Biologics Inc.盘中异动 下午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546725523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546725523?lang=zh_cn&edition=full","pubTime":"2025-06-28 02:12","pubTimestamp":1751047930,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日02时12分，Abcellera Biologics Inc.股票出现异动，股价快速下挫5.04%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628021211a4c1b4b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628021211a4c1b4b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","ABCL","BK4121"],"gpt_icon":0},{"id":"2545236308","title":"Abcellera Biologics Inc.盘中异动 大幅拉升5.11%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545236308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545236308?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:27","pubTimestamp":1750775226,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时27分，Abcellera Biologics Inc.股票出现波动，股价快速上涨5.11%。截至发稿，该股报3.50美元/股，成交量114.126万股，换手率0.38%，振幅4.20%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624222706a71b688c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624222706a71b688c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4535","BK4121"],"gpt_icon":0},{"id":"2544176755","title":"Abcellera Biologics Inc.盘中异动 快速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544176755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544176755?lang=zh_cn&edition=full","pubTime":"2025-06-20 23:06","pubTimestamp":1750431983,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日23时06分，Abcellera Biologics Inc.股票出现异动，股价快速下跌5.19%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202306249524e676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202306249524e676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","ABCL","BK4121"],"gpt_icon":0},{"id":"2544906678","title":"Abcellera Biologics Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544906678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544906678?lang=zh_cn&edition=full","pubTime":"2025-06-18 22:15","pubTimestamp":1750256131,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日22时15分，Abcellera Biologics Inc.股票出现异动，股价大幅拉升5.13%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506182215319521ee19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506182215319521ee19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4535","BK4121"],"gpt_icon":0},{"id":"2544864995","title":"Abcellera Biologics Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544864995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544864995?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:49","pubTimestamp":1750168153,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时49分，Abcellera Biologics Inc.股票出现异动，股价急速拉升5.06%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061721491497837c17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061721491497837c17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2542310044","title":"Abcellera Biologics Inc.盘中异动 股价大涨5.38%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542310044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542310044?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:53","pubTimestamp":1749563602,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时53分，Abcellera Biologics Inc.股票出现波动，股价急速拉升5.38%。截至发稿，该股报2.65美元/股，成交量77.1359万股，换手率0.26%，振幅4.18%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610215323951661b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610215323951661b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4535","ABCL"],"gpt_icon":0},{"id":"2541869121","title":"Abcellera Biologics Inc.盘中异动 急速拉升5.06%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541869121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541869121?lang=zh_cn&edition=full","pubTime":"2025-06-06 23:14","pubTimestamp":1749222849,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日23时14分，Abcellera Biologics Inc.股票出现波动，股价急速上涨5.06%。截至发稿，该股报2.49美元/股，成交量125.026万股，换手率0.42%，振幅4.64%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606231409a6fd5f00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606231409a6fd5f00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","ABCL","BK4121"],"gpt_icon":0},{"id":"2540705864","title":"Abcellera Biologics Inc.盘中异动 临近午盘股价大涨5.14%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540705864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540705864?lang=zh_cn&edition=full","pubTime":"2025-06-03 23:37","pubTimestamp":1748965056,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日23时37分，Abcellera Biologics Inc.股票出现异动，股价快速拉升5.14%。截至发稿，该股报2.25美元/股，成交量154.565万股，换手率0.52%，振幅7.01%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603233736950d1f21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603233736950d1f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2540794551","title":"Abcellera Biologics Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540794551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540794551?lang=zh_cn&edition=full","pubTime":"2025-06-02 23:16","pubTimestamp":1748877381,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日23时16分，Abcellera Biologics Inc.股票出现波动，股价急速上涨5.06%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602231622a6f73a27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602231622a6f73a27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4121","ABCL"],"gpt_icon":0},{"id":"2537647718","title":"Abcellera Biologics Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537647718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537647718?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:06","pubTimestamp":1747764372,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时06分，Abcellera Biologics Inc.股票出现异动，股价快速上涨5.20%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020612a485b605&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020612a485b605&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXS","BK4082","ABCL","BK4535","BK4121"],"gpt_icon":0},{"id":"2536582570","title":"Abcellera Biologics Inc.2025财年第一财季实现净利润-45.62百万美元，同比减少12.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582570","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536582570?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497642,"startTime":"0","endTime":"0","summary":"5月18日，Abcellera Biologics Inc.公布财报，公告显示公司2025财年第一财季净利润为-45.62百万美元，同比减少12.34%；其中营业收入为4.24百万美元，同比减少57.39%，每股基本收益为-0.15美元。从资产负债表来看，Abcellera Biologics Inc.总负债1.64亿美元，其中短期债务4.64百万美元，资产负债比为8.20，流动比率为0.11。机构评级：截至2025年5月18日，当前有7家机构对Abcellera Biologics Inc.目标价做出预测，其中目标均价为8.43美元，其中最低目标价为5.00美元，最高目标价为17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000335a6e2d8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000335a6e2d8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL"],"gpt_icon":0},{"id":"2536349395","title":"Truist Securities：维持AbCellera Biologics(ABCL.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536349395","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536349395?lang=zh_cn&edition=full","pubTime":"2025-05-17 01:56","pubTimestamp":1747418170,"startTime":"0","endTime":"0","summary":"Truist Securities：维持AbCellera Biologics(ABCL.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至10.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/17015650465765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ABCL"],"gpt_icon":0},{"id":"2535208030","title":"Abcellera Biologics Inc.盘中异动 大幅拉升5.24%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535208030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535208030?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:41","pubTimestamp":1747230061,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时41分，Abcellera Biologics Inc.股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.21美元/股，成交量33.3572万股，换手率0.11%，振幅4.76%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4535","BK4007","SEPN","ABCL"],"gpt_icon":0},{"id":"2534548086","title":"Abcellera Biologics Inc.盘中异动 早盘快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534548086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534548086?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:31","pubTimestamp":1746797495,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时31分，Abcellera Biologics Inc.股票出现波动，股价快速上涨5.01%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921313594f1d563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921313594f1d563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL","BK4121","BK4535"],"gpt_icon":0},{"id":"2533061650","title":"Abcellera Biologics Inc.盘中异动 急速下跌5.02%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533061650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533061650?lang=zh_cn&edition=full","pubTime":"2025-05-07 01:33","pubTimestamp":1746552805,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时33分，Abcellera Biologics Inc.股票出现波动，股价急速下挫5.02%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体跌幅为5.77%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070133259750ebeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070133259750ebeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","ABCL","BK4121"],"gpt_icon":0},{"id":"2527021121","title":"Keybanc：维持AbCellera Biologics评级，由增持调整至增持评级, 目标价由4.00美元调整至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527021121","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527021121?lang=zh_cn&edition=full","pubTime":"2025-04-16 20:27","pubTimestamp":1744806476,"startTime":"0","endTime":"0","summary":"Keybanc：维持AbCellera Biologics(ABCL.US)评级，由增持调整至增持评级, 目标价由4.00美元调整至5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504162030419739ef17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504162030419739ef17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABCL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abcellera.com","stockEarnings":[{"period":"1week","weight":0.1253},{"period":"1month","weight":0.6813},{"period":"3month","weight":1.0386},{"period":"6month","weight":0.4452},{"period":"1year","weight":0.4965},{"period":"ytd","weight":0.4403}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AbCellera Biologics Inc.于2012年11月8日根据不列颠哥伦比亚省商业公司法注册成立并开始经营活动。该公司从事的业务是在其医学研究和开发中综合运用多种复杂技术，以更快、更廉价、更有效地发掘抗体药物。自成立以来，公司一直致力于研发活动，以支持其目前的合作伙伴项目和未来的平台开发工作。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.008427},{"month":2,"riseRate":0,"avgChangeRate":-0.143182},{"month":3,"riseRate":0.2,"avgChangeRate":-0.064544},{"month":4,"riseRate":0.2,"avgChangeRate":-0.104908},{"month":5,"riseRate":0.6,"avgChangeRate":-0.032152},{"month":6,"riseRate":0.4,"avgChangeRate":0.119513},{"month":7,"riseRate":0.6,"avgChangeRate":0.032107},{"month":8,"riseRate":0.5,"avgChangeRate":-0.084951},{"month":9,"riseRate":0.5,"avgChangeRate":-0.005007},{"month":10,"riseRate":0.5,"avgChangeRate":-0.019108},{"month":11,"riseRate":0.75,"avgChangeRate":0.07218},{"month":12,"riseRate":0.25,"avgChangeRate":-0.01782}],"exchange":"NASDAQ","name":"AbCellera Biologics","nameEN":"AbCellera Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AbCellera Biologics(ABCL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AbCellera Biologics(ABCL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AbCellera Biologics,ABCL,AbCellera Biologics股票,AbCellera Biologics股票老虎,AbCellera Biologics股票老虎国际,AbCellera Biologics行情,AbCellera Biologics股票行情,AbCellera Biologics股价,AbCellera Biologics股市,AbCellera Biologics股票价格,AbCellera Biologics股票交易,AbCellera Biologics股票购买,AbCellera Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AbCellera Biologics(ABCL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AbCellera Biologics(ABCL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}